PRIMARY STUDY
Effects of Delta9-tetrahydrocannabivarin on [35S]GTPgammaS binding in mouse brain cerebellum and piriform cortex membranes
Key Findings: Delta-9-THCV are CB1 receptor antagonists in the cerebellum and piriform cortical.
Type of Study: Laboratory Study
Study Result: Inconclusive
Research Location(s): United Kingdom
Year of Pub: 2019
Cannabinoids Studied: Tetrahydrocannabivarin (THCV)
Phytocannabinoid Source: Unspecified
Receptors Studied: CB1
Route of Administration: In vitro
Citation: Dennis I, et al. Effects of Delta9-tetrahydrocannabivarin on [35S]GTPgammaS binding in mouse brain cerebellum and piriform cortex membranes. Br J Pharmacol. 2008; 154:1349-58. doi: 10.1038/bjp.2008.190
Authors: Dennis I, Whalley BJ, Stephens GJ
